Inventor · disambiguated record
Paul Graham Wyatt
Also filed as: WYATT PAUL · WYATT PAUL G · WYATT PAUL GRAHAM
28 granted patents·20 pending applications·219 citations·filing 1988–2023
96Inventor score
Files withASTEX THERAPEUTICS LTD26BERDINI VALERIO7BEECHAM GROUP PLC4GLAXO GROUP LTD2ASTEX TECHNOLOGY INC1
Top patents by PatentIndex Score
48 records- 0195US7385059B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jun 10, 2008·33 cites·20 claims
- 0291US8110573B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2005·Granted Feb 7, 2012·9 cites·17 claims
- 0390US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 0490US4965270APurine derivativesBEECHAM GROUP PLC·Filed 1989·Granted Oct 23, 1990·30 cites·13 claims
- 0588US7825140B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Nov 2, 2010·7 cites·19 claims
- 0688US7745638B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Jun 29, 2010·8 cites·23 claims
- 0785US8367673B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2009·Granted Feb 5, 2013·8 cites·11 claims
- 0885US8080666B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2010·Granted Dec 20, 2011·6 cites·19 claims
- 0984US8013163B24-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Sep 6, 2011·7 cites·22 claims
- 1083US8541579B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Granted Sep 24, 2013·6 cites·1 claims
- 1181US9156811B2N-myristoyl transferase inhibitorsBRAND STEPHEN·Filed 2009·Granted Oct 13, 2015·9 cites·3 claims
- 1281US7514437B2Substituted diketopiperazines as oxytocin antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 7, 2009·15 cites·12 claims
- 1380US8546407B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsBERDINI VALERIO·Filed 2005·Granted Oct 1, 2013·4 cites·18 claims
- 1479US8778936B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 1578US4910307AProcess for preparing purinesBEECHAM GROUP PLC·Filed 1988·Granted Mar 20, 1990·12 cites·7 claims
- 1677US8779147B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·14 claims
- 1776US9006430B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as proteinASTEX THERAPEUTICS LTD·Filed 2014·Granted Apr 14, 2015·2 cites·20 claims
- 1876US8691806B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 1975US8809336B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Aug 19, 2014·2 cites·13 claims
- 2073US8404718B2Combinations of pyrazole kinase inhibitorsCURRY JAYNE ELIZABETH·Filed 2010·Granted Mar 26, 2013·5 cites·22 claims
- 2173US8247576B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2004·Granted Aug 21, 2012·5 cites·8 claims
- 2267US8293767B24-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitorsWYATT PAUL GRAHAM·Filed 2011·Granted Oct 23, 2012·2 cites·16 claims
- 2366US9828346B2N-myristoyl transferase inhibitorsUNIV DUNDEE·Filed 2015·Granted Nov 28, 2017·1 cites·12 claims
- 2465US9051278B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Jun 9, 2015·0 cites·24 claims
- 2562US9283226B2Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 15, 2016·0 cites·20 claims
- 2662US5159076APurine intermediatesBEECHAM GROUP PLC·Filed 1990·Granted Oct 27, 1992·6 cites·4 claims
- 2757US2025129084A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Application pending·0 cites
- 2855US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 2953US2016250187A1Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 3052US2008194562A1Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk'sASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3152US2008306069A1Pyrazole Derivatives for the Inhibition of CDK'S and GSK'SASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3251US2011224203A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2011·Application pending·0 cites
- 3350US7149280B2Synthesis and screening of ligands using X-ray crystallographyASTEX THERAPEUTICS LTD·Filed 2003·Granted Dec 12, 2006·0 cites·12 claims
- 3448US2009036435A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3546US2008312223A1Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora KinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3646US2007105900A1Pharmaceutical compoundsATEX THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 3746US2008167309A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3845US2006135589A11h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitorsASTEX TECHNOLOGY INC·Filed 2003·Application pending·0 cites
- 3945US2009318500A14-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of CancerASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 4044US2008139620A1Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk'sASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 4143US2010160324A1Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 4243US2006135516A13-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitorsASTEX TECHNOLOGY LTD·Filed 2003·Application pending·0 cites
- 4342US2008275029A1Compounds for Treating Protein-Kinase Mediated DisordersASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 4442US2008004270A13,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) InhibitorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 4541US2009099213A1Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases InhibitorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 4638US2008161355A1Combinations of Pyrazole Kinase Inhibitors and Further Antitumor AgentsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 4738US2008161251A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 4837US5252575AAntiviral purine derivatives with improved gastrointestinal absorptionBEECHAM GROUP PLC·Filed 1992·Granted Oct 12, 1993·1 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →